21 CFR 520.2654

§ 520.2654 Velagliflozin.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 520.2654, § 520.2654 Velagliflozin, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87375
Permanent ID: ys:prov:87375@1
SHA-256: dfbc4abaef5fd51ca9bf92e41954018e04bd5c879b737d3e5dc74d3b642ee3a0

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each milliliter of solution contains 15 milligrams (mg) velagliflozin. (b) Sponsor. See No. 000010 in § 510.600(c) of this chapter. (c) Conditions of use—(1) Amount. Administer orally 0.45 mg per pound of body weight (1 mg per kilogram) velagliflozin once daily. (2) Indications for use. To improve glycemic control in otherwise healthy cats with diabetes mellitus not previously treated with insulin. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.